최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea, v.27 no.11, 2004년, pp.1081 - 1085
Kaplancikli, Zafer-Asim (Anadolu University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry) , Gulhan, Turan-Zitouni (Anadolu University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry) , Revial, Gilbert (Laboiratoire de Chimie Organique, CNRS (ESA 7084) ESPCI) , Guven, Kiymet (Anadolu University, Faculty of Science, Department of Biology)
Several 2-[[(benzoxazole/benzimidazole-2-yl)sulfanyl]acetylamino]thiazoles derivatives were synthesized by reacting 4-substituted-2-(chloroacetylamino)thiazoles with benzoxazole/benzimidazole-2-thioles in acetone and in the presence of
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Alexander, B. D. and Perfect, J. R., Antifungal resistance trends towards the year 2000 Implications for therapy and new approaches. Drugs, 54, 657-678 (1997)
Amyes, S. G. B. and Gemmell, C. G., Antibiotic resistance Proceedings of a symposium held on 12 July 1996 at the University of Southampton. J. Med. Microbiol., 46, 436-470(1997)
Ates, O., Altintas, H. and Otuk, G., Synthesis and antimicrobial activity of 4-carbethoxymethyl-2-[(alpha-haloacyl)amino]thiazoles and 5-nonsubstituted/stituted 2-[(4-carbethoxy-methylthiazol-2-yl)imino]-4-thiazolidinones. Arzneim. Forsch., 50, 569-575 (2000).
Cassell, G. H. and Mekalanos, J., Development of antimicrobial agents in the era of new and reemerging infectious diseases and increasing antibiotic resistance. J. Am. Med. Assoc., 285, 601-605 (2001)
Cetinkaya, Y., Falk, P., and Mayhall, C.G., Vancomycin-resistant enterococci. Clin. Microbiol. Rev., 13, 686-707 (2000)
Chu, D. T. W., Plattner, J. J., and Katz, L., New directions in antibacterial research. J. Med. Chem., 39, 3853-3874 (1996)
Cunha, B. A., Antibiotic resistance. Drugs Today, 34, 691-698 (1998)
Doern, G. V., Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. Clin. lnfect. Dis., 33,187-192 (2001)
Goodman-Gilman, A., The pharmacological basis of therapeutics. McGraw-Hill company, USA, (2001)
Gringauz, A., Introduction to Medicinal Chemistry, How Drug Act and Why., Wiley-VCH Inc., USA (1997)
Healy, V. L., Lessard, I. A. D., Roper, D. I., Knox, J. R. and Walsh, C. T., Vancomycin resistance in enterococci: reprogramming of the D-Ala-D-Ala ligases in bacterial peptidoglycan biosynthesis. Chem. Biol., 7, 109-119 (2000)
Hood, S. and Denning, D. W., Treatment of fungal infection in AIDS, J. Antimicrob. Chemoth., 37, 71-85 (1996)
Hubschwerlen, C., Pflieger, P., Specklin, J. L., Gubernator, K., Gmunder, H., Angehrn, P., and Kompis, I., Pyrimido[1,6-a]benzimidazoles: a new class of DNA gyrase inhibitors. J. Med. Chem., 35, 1385-1392 (1992)
Joule, J. A. and Mills, K., Heterocyclic Chemistry, Blackwell Science Ltd., Oxford, (2000)
Kim J. S., Sun, Q., Gatto, B., Yu, C., Liu, A., Liu, L. F., and LaVoie, E. J., Structure-activity relationships of benzimidazoles and related heterocycles as topoisomerase I poisons. Bioorg. Med. Chem., 4, 621-630 (1996)
Koneman, E. W., Allen, S. D., and Winn, W. C., Colour Atlas and Textbook of Diagnostic Microbiology, Lippincott Raven Pub., Philadelphia, (1997)
Lakhan, R., Sharma, B. P., and Shukla, B. N., Synthesis and antimicrobial activity of 1-aryl-2-amino-3-(4-arylthiazol-2-yl)/(benzothiazol-2-yl)guanidines. Farmaco, 55, 331-337 (2000)
Levy, S. B., The challenge of antibiotic resistance. Sci. Am., 278, 46-53 (1998)
Lipsitch, M., The rise and fall of antimicrobial resistance. Trends Microbiol., 9, 438-444 (2001)
Lopez-Garcia, B., Veyrat, A., Perez-Paya, E., Gonzalez-Candelas, L., and Marcos, J. F., Comparison of the activity of antifungal hexapeptides and the fungicides thiabendazole and imazalil against postharvest fungal pathogens. Int. J. Food Microbiol., 89, 163-170, (2003)
Marchese, A., Schito, G. C., and Debbia, E. A, Evolution of antibiotic resistance in gram-positive pathogens. J. Chemotherapy, 12, 459-462 (2000)
Onoe, H. and Takahashi, H., Jpn. Kokai. Tokkyo Koho JP 03 87,841 (1994). Chem. Abstr., 121,205336 (1994)
Pandeya, S. N., Sriram, D., and Nath, G., Synthesis, antibacterial, antifungal and anti-HIV activities of Schiff and Mannich bases derived from isatin derivatives and N-[4-(4'-chlorophenyl)thiazol-2-yl] thiosemicarbazide. Eur. J. Pharm. Sci., 9, 25-31 (1999)
Perrin, L., Rakik, A., Yerly, S., Baumberger, C., Kinlochde-Loes, S., Pechere, M., and Hirschel, B., Combined therapy with zidovudine and L-697,661 in primary HIV infection. AIDS, 10, 1233-1237 (1996)
Rapp, R. P., Antimicrobial resistance in gram-positive bacteria: The myth of the MIC. Pharmacotherapy, 19, 112-119 (1999)
Rybak, M. J. and Akins, R. L., Emergence of methicillin-resistant Staphylococcus aureus with intermediate glycopeptide resistance-Clinical significance and treatment options. Drugs, 6,1-7 (2001)
Silverman, R. B., Organic chemistry of Drug Desing and Drug Action, Academic press, San Diego, (1992)
Thompson, L. A. and Ellman, J. A., Synthesis and applications of small molecule libraries. Chem. Rev., 96, 555-600 (1996)
Turan-Zitouni, G. and Kaplancikli, Z. A., Some new 2,3-dihydro-3-benzofuranamine derivatives. Boll. Chim. Farmaceutico, 137, 367-371 (1998)
Turan-Zitouni, G., Demirayak, S., Ozdemir, A., Kaplancikli, Z. A., and Yildiz, M. T., Synthesis of some 2-[(benzazole-2yl)thioacetylamino]thiazole derivatives and their antimicrobial activity and toxicity. Eur. J. Med. Chem., 39, 267-272 (2004)
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Free Access. 출판사/학술단체 등이 허락한 무료 공개 사이트를 통해 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.